8/4/2021  9:31:52 AM Chg. +0.1700 Volume Bid9:54:07 AM Ask9:54:07 AM Market Capitalization Dividend Y. P/E Ratio
45.3000EUR +0.38% 980
Turnover: 44,274.5000
45.4300Bid Size: 553 45.4300Ask Size: 553 25.25 bill.EUR 1.94% 14.80

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Stephan Sturm
Management board
Rachel Empey, Dr. Ernst Wastler, Dr. Francesco De Meo, Michael Sen, Rice Powell, Sebastian Biedenkopf
Supervisory board
Wolfgang Kirsch, Grit Genster, Michael Diekmann, Bernd Behlert, Frauke Lehmann, Hauke Stars, Klaus-Peter Müller, Konrad Kölbl, Oscar Romero De Paco, Prof. Dr. D. Michael Albrecht, Prof. Dr. Iris Löw-Friedrich, Stefanie Balling
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 56.49%
IPO date: 12/18/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Main Shareholders

Freefloat
 
56.49%
Else Kröner-Fresenius-Stiftung
 
27.00%
BlackRock, Inc.
 
4.74%
Allianz Global Investors GmbH
 
2.98%
DWS Investment GmbH
 
2.98%
The Capital Group Companies, Inc.
 
2.92%
Henderson Group plc
 
2.89%